Non-Invasive Finger Arterial Pressure Monitors Capable of Providing Dynamic Preload Variables
The Nexfin/Finometer device (now marketed as ClearSight) is the primary non-invasive finger arterial pressure monitor validated for providing stroke volume variation (SVV), pulse pressure variation (PPV), and systolic pressure variation (SPV) to predict volume responsiveness.
Device Capabilities
The Nexfin monitor uses volume clamp plethysmography technology applied to a finger cuff to continuously measure beat-to-beat arterial blood pressure non-invasively. This technology enables calculation of:
- Pulse Pressure Variation (PPV) 1, 2, 3
- Stroke Volume Variation (SVV) 1, 2
- Systolic Pressure Variation (SPV) 3
- Continuous cardiac output/cardiac index 1
Clinical Validation Evidence
Accuracy Compared to Invasive Monitoring
The Nexfin device has been rigorously validated against invasive arterial line measurements in mechanically ventilated patients:
- PPV correlation: r=0.96 with mean bias of -0.95% and narrow limits of agreement (-4.3% to 2.4%) 3
- SPV correlation: r=0.95 with mean bias of -0.22% and limits of agreement (-2.2% to 1.7%) 3
- The device adequately reflects alterations in PPV and SVV during provoked fluid shifts 1
Predictive Performance for Fluid Responsiveness
When using the Nexfin device, the ability to predict fluid responsiveness varies based on the threshold definition:
- SVV performance: Superior to PPV with AUC of 0.728-0.944 depending on the stroke volume increase threshold used 1, 2
- PPV performance: AUC ranges from 0.818 at 10% SVI increase threshold to 0.928 at 25% SVI increase threshold 2
- Predictive ability improves substantially at higher thresholds of stroke volume increase (≥15-25%) with concomitantly smaller "grey zones" 2
Clinical Application Framework
When to Use These Variables
Based on the 2025 ESICM guidelines 4, PPV and SVV should be used under specific conditions:
Recommended conditions (AUROC 0.94):
- Controlled mechanical ventilation
- Tidal volume ≥8 mL/kg predicted body weight
- No spontaneous breathing activity
- Regular cardiac rhythm
Caution advised (AUROC 0.74):
- Tidal volume <8 mL/kg
- Any spontaneous breathing activity present
Important Limitations and Pitfalls
False Positives occur with:
- Spontaneous ventilation
- Cardiac arrhythmias
- Right ventricular failure
False Negatives occur with:
- Low tidal volumes (<8 mL/kg)
- Low lung compliance
- Very high respiratory rates
- Intra-abdominal hypertension (may increase thresholds)
Threshold Values and Grey Zones
The optimal cut-off values for the Nexfin device vary based on your definition of fluid responsiveness 2:
- For 10% SVI increase: PPV 9-16% (grey zone), SVV 5-13% (grey zone)
- For 15% SVI increase: More reliable prediction
- For 25% SVI increase: PPV 18-21% (grey zone), SVV 14-16% (grey zone) with best discrimination
High PPV/SVV values reliably predict fluid responsiveness, while lower values are less reliable 4.
Alternative Approaches When Conditions Are Not Ideal
When the validity criteria for PPV/SVV are not met, the 2025 ESICM guidelines 4 recommend:
- Passive leg raising (PLR) test - First choice, works with or without spontaneous breathing (AUROC 0.94)
- End-expiratory occlusion test - Alternative for patients without spontaneous breathing
- PPV/SVV changes during functional tests - Promising advance that overcomes classic limitations by measuring the decrease in PPV during PLR or increase during tidal volume challenge
Device-Specific Considerations
The Finometer PRO (newer version) has also been validated for capturing peripheral pressure waveforms that allow estimation of central pressure characteristics 5, though this study focused on pressure waveform analysis rather than dynamic preload variables specifically.
Critical caveat: Age may affect the agreement between PPV and SVV measurements, with different median bias in patients younger versus older than 55 years 1, though the clinical significance of this finding requires further investigation.